C39H43NO12
Neat
717.77
N-Benzyladriamycin-14-valerate; 98983-21-2; AD-198; DTXSID40243893; RefChem:909022; DTXCID70166384; 2-(1, 2, 3, 4, 6, 11-Hexahydro-2, 5, 12-trihydroxy-7-methoxy-6, 11-dioxo-4-((2, 3, 6-trideoxy-3-((phenylmethyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphthacenyl)-2-oxoethyl (2S, 4S)-pentanoate; [2-[(2S, 4S)-4-[(2R, 4S, 5S, 6S)-4-(benzylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-2, 5, 12-trihydroxy-7-methoxy-6, 11-dioxo-3, 4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] pentanoate; SCHEMBL30139090; Pentanoic acid, 2-(1, 2, 3, 4, 6, 11-hexahydro-2, 5, 12-trihydroxy-7-methoxy-6, 11-dioxo-4-((2, 3, 6-trideoxy-3-((phenylmethyl)amino)-alpha-L-lyxo-hexopyranoxyl)oxy)-2-naphthacenyl)-2-oxoethyl ester and (2S-cis)-
[2-[(2S, 4S)-4-[(2R, 4S, 5S, 6S)-4-(benzylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-2, 5, 12-trihydroxy-7-methoxy-6, 11-dioxo-3 and 4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] pentanoate
InChI=1S/C39H43NO12/c1-4-5-14-28(42)50-19-27(41)39(48)16-23-31(38(47)33-32(36(23)45)35(44)22-12-9-13-25(49-3)30(22)37(33)46)26(17-39)52-29-15-24(34(43)20(2)51-29)40-18-21-10-7-6-8-11-21/h6-13,20,24,26,29,34,40,43,45,47-48H,4-5,14-19H2,1-3H3/t20-,24-,26-,29-,34+,39-/m0/s1